Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trial

Peter Norwood, Christina Yau, Denise Wolf +4

The I-SPY2 phase 2 clinical trial is a long-running platform trial that evaluates neoadjuvant treatments for locally advanced breast cancer, assigning subjects to novel agents usin…